Proteomedix is a Swiss diagnostics company and spin-out of ETH Zurich dedicated to developing innovative diagnostic solutions, such as prostate cancer tests.
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Proteomedix →Already a subscriber? Sign in
Xcout Intel tracks Proteomedix continuously — this profile deepens as new filings, funding, people and hiring data arrive.